Drug Profile
Research programme: type 1 diabetes therapy - JDRF/Novartis
Latest Information Update: 11 Aug 2009
Price :
$50
*
At a glance
- Originator JDRF; Novartis
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Phase Unknown Type 1 diabetes mellitus
Most Recent Events
- 05 Aug 2009 Investigation in Type-1 diabetes mellitus in USA (unspecified route)